Keyphrases
Atypical Teratoid Rhabdoid Tumor (AT/RT)
27%
Brain Tumor
13%
Central Nervous System Tumors
7%
Chemotherapy
5%
Childhood Brain Tumors
6%
Chromothripsis
6%
Clinical Trials
8%
DNA Methylation (DNAm)
5%
DNA Methylation Profiling
7%
Embryonal Tumor with multilayered Rosettes
12%
Ependymoma
23%
Gene Expression
8%
Genetic Modification
8%
Glioblastoma
6%
Group 3 Medulloblastoma
6%
Human Cancer
6%
Medulloblastoma
100%
Medulloblastoma Subgroups
9%
Molecular Analysis
9%
Molecular Characteristics
5%
Molecular Characterization
10%
Molecular Subgrouping
5%
Molecular Subgroups
19%
Mouse Model
6%
Multidrug Resistance Protein
10%
Multidrug Resistance Protein 1 (MDR1)
7%
Multidrug Resistance-associated Protein 2 (MRP2)
8%
Myxopapillary Ependymoma
8%
Overall Survival
8%
Overexpression
8%
Pan-cancer Analysis
13%
Pediatric
16%
Pediatric Brain Tumor
9%
Pilocytic Astrocytoma
5%
Poor Prognosis
6%
Posterior Fossa
6%
Posterior Fossa Ependymoma
6%
Progression-free Survival
7%
Rhabdoid Tumor
9%
Risk Stratification
6%
SMARCB1
18%
Sonic Hedgehog
19%
Sonic Hedgehog Medulloblastoma
11%
Supratentorial
7%
Therapeutic Target
6%
TP53 mutation
7%
Tumor
70%
Tumor Subtype
9%
Tumorigenesis
8%
Whole Genome
17%
Biochemistry, Genetics and Molecular Biology
Adolescence
5%
Carcinogenesis
12%
Cell Cycle
5%
Chromatin Remodeling
5%
Chromothripsis
7%
Clinical Trial
16%
Cytogenetics
6%
DNA Methylation
30%
Enhancer Region
5%
Epigenetics
14%
Gene Expression
12%
Gene Expression Profiling
13%
Gene Mutation
10%
Genetics
19%
Genomics
29%
Germ Cell
8%
Germline
8%
Hedgehog Signaling Pathway
7%
Histone
5%
Messenger RNA
10%
Methylation
19%
MicroRNA
9%
Mouse Model
8%
Multidrug Resistance-Associated Protein 2
7%
Oncogene
8%
Overall Survival
9%
P-Glycoprotein
5%
Pan-cancer
8%
Progression Free Survival
6%
Promoter Region
9%
RNA
5%
RNA Sequence
10%
Rosette Formation
8%
SMARCA4
6%
SMARCB1
19%
Somatic Mutation
6%
Sonic Hedgehog
24%
Stem Cell
5%
Transcription Factors
5%
Transcriptome
10%
Transcriptomics
5%
Whole Genome Sequencing
12%
Medicine and Dentistry
Atypical Teratoid Rhabdoid Tumor
21%
Cancer
6%
Central Nervous System
8%
Central Nervous System Tumor
9%
Chemotherapy
5%
Childhood Cancer
5%
Clinical Trial
5%
Diagnosis
6%
Disease
6%
DNA Methylation
14%
Ependymoma
10%
Ganglioglioma
7%
Glioblastoma
10%
In Vitro
6%
Intracranial Tumor
14%
Malignant Neoplasm
22%
Medulloblastoma
55%
Metastatic Carcinoma
6%
Methylation
8%
microRNA
6%
Multidrug Resistance Associated Protein 2
6%
Neoplasm
73%
Neuroepithelioma
8%
Organoid
5%
Overall Survival
7%
Pediatric Cancer
6%
Pediatrics
21%
Primary Tumor
5%
Radiation Therapy
5%
Rosette Formation
13%
Somatics
6%
Sonic Hedgehog Protein
14%
Tumor
5%
Xenograft
5%
